Acting Director of the Hong Kong Economic and Trade Office (Toronto) (HKETO), Mr Gavin Yeung, briefed Canadian healthcare professionals and investors on Hong Kong’s strengths and latest developments in healthcare infrastructure at a webinar co-organised by Hong Kong Trade Development Council in Canada, Invest Hong Kong (InvestHK) in Canada, and Hong Kong-Canada Business Association (Ottawa Chapter) on March 20.
In his opening remarks, Mr Yeung highlighted Hong Kong’s rapid development and advantages in the field of innovation and technology. “Hong Kong is the only city in Asia with five ‘Top 100 universities’,” he said. “Together with two of the world’s top 40 medical schools, Hong Kong boasts world-leading research and development (R&D) capabilities, offering the city significant advantages in developing life and health technologies.”
Mr Yeung cited that Hong Kong has set up flagship research clusters at the Hong Kong Science Park including Health@InnoHK, which collaborates with world-renowned universities and research institutes to drive research on healthcare technologies.
“To facilitate R&D activities and transformation outcomes, we have committed HK$6 billion (CAD$1.1 billion) in funding for universities and research institutes to establish life and health technology research institutes in Hong Kong,” Mr Yeung added.
Looking ahead, Mr Yeung said that Hong Kong will continue to leverage its unique advantages under the “one country, two systems” and develop into an international innovation and technology centre, as well as a health and medical innovation hub in the Asia-Pacific region.
Before closing, Mr Yeung encouraged participants to join a Canadian healthcare delegation to Hong Kong for the Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair in May.
Head of InvestHK (Canada), Mr Christopher Chen, also spoke at the webinar providing an overview of the healthcare and research ecosystem in Hong Kong, highlighting the city’s edges in the healthcare industry development.
香港經貿處署理處長推廣香港醫療發展優勢
香港駐多倫多經濟貿易辦事處（香港經貿處）署理處長楊江鋒於三月二十日出席由香港貿易發展局加拿大辦事處、香港投資推廣署加拿大辦事處及港加商會（渥太華分會）聯合舉辦的網上研討會，向加拿大醫療專才及投資者介紹香港在醫療基建方面的優勢及最新發展。
楊江鋒致開幕辭時介紹香港在創新科技領域的快速發展和優勢。他表示：「香港是亞洲唯一擁有五所『百強大學』的城市，同時亦擁有兩所全球排名前40的醫學院，可見香港在科研方面具有世界領先的實力，在發展生命健康科技上有顯著優勢。」
楊江鋒舉例，香港科學園設立了包括Health@InnoHK在內的旗艦研發項目，與世界知名學府和研究機構合作進行醫療科技研究。
他補充說：「為推動科研活動及科技成果轉化，香港承諾撥款60億港元（11億加元）資助大學及科研機構在香港設立生命健康科技研究院。」
展望未來，楊江鋒表示香港將持續發揮「一國兩制」的獨特優勢，發展成為國際科技創新中心及亞洲醫療創新樞紐。
最後，楊江鋒鼓勵與會者參加加拿大醫療代表團，於五月份前往香港出席亞洲醫療健康高峰論壇及香港國際醫療及保健展。
香港投資推廣署加拿大辦事處投資推廣總監陳立智也在網上研討會上介紹香港的醫療及科研生態系統，以及香港醫療產業的最新發展。
.gif)
